The Egyptian Journal of Bronchology最新文献

{"title":"Correction: Hematological parameters as predictors of OSA severity","authors":"Rasha Mohamed Hendy, Basma M. Hani, Salwa H. Mohammed","doi":"10.1186/s43168-024-00258-1","DOIUrl":"https://doi.org/10.1186/s43168-024-00258-1","url":null,"abstract":"<p><b>Correction: Egypt J Bronchol 18, 3 (2024)</b></p><p><b>https://doi.org/10.1186/s43168-023-00252-z</b></p><br/><p>The original publication of this article contained an incorrect author name. The incorrect and correct information is shown in this correction article [1]. The original article has been updated.</p><p>Incorrect</p><p>Basma M. Hani</p><p>Correct</p><p>Basma H. Hani</p><ol data-track-component=\"outbound reference\"><li data-counter=\"1.\"><p>Hendy RM et al (2024) Hematological parameters as predictors of OSA severity. Egypt J Bronchol 18:3. https://doi.org/10.1186/s43168-023-00252-z</p><p>Article Google Scholar </p></li></ol><p>Download references<svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></p><h3>Authors and Affiliations</h3><ol><li><p>Departments of Chest Diseases, Benha University, Banha, Egypt</p><p>Rasha Mohamed Hendy &amp; Salwa H. Mohammed</p></li><li><p>Community Department, Benha University, Banha, Egypt</p><p>Basma M. Hani</p></li></ol><span>Authors</span><ol><li><span>Rasha Mohamed Hendy</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Basma M. Hani</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Salwa H. Mohammed</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li></ol><h3>Corresponding author</h3><p>Correspondence to Salwa H. Mohammed.</p><p><b>Open Access</b> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.</p>\u0000<p>Reprints and permissions</p><img alt=\"Check for updates. Verify currency and authenticity via CrossMark\" height=\"81\" loading=\"lazy\" src=\"data:image/svg+xml;base64,PHN2ZyBoZWlnaHQ9IjgxIiB3aWR0aD0iNTciIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyI+PGcgZmlsbD0ibm9uZSIgZmlsbC1ydWxlPSJldmVub2RkIj48cGF0aCBkPSJtMTcuMzUgMzUuNDUgMjEuMy0xNC4ydi0xNy4wM2gtMjEuMyIgZmlsbD0iIzk4OTg5OCIvPjxwYXRoIGQ9Im0zOC42NSAzNS40NS0yMS4zLTE0LjJ2LTE3LjAzaDIxLjMiIGZpbGw9IiM3NDc0NzQiLz48c","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":"80 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140009665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"12-month risk factor evaluation for persistent pulmonary symptoms in long COVID-19 patients","authors":"Eman M. Emad Eldin, Randa S. Mohammed, Mahmoud M. E. L. Batanony, Laila A. Al-Sharawy","doi":"10.1186/s43168-024-00265-2","DOIUrl":"https://doi.org/10.1186/s43168-024-00265-2","url":null,"abstract":"Knowledge of the sequelae of new coronavirus disease 2019 (COVID-19) is still limited owing to the relative recent onset of the disease. However, the study of other different types of coronavirus infections prior to COVID-19 infection reports that the patients may experience persistent symptoms following the infection. Assessment and follow-up of persistent respiratory symptoms in patients recovered from acute COVID-19 infection. In this prospective cohort study, COVID-19 patients diagnosed at Beni-Suef University hospital and followed up prospectively at 3, 6, and 12 months after discontinuation of quarantine. Patients were interviewed for persistent respiratory symptoms then underwent assessment by physical examination and routine labs. Seventy-one patients were evaluated and participated in this study. The mean age of the patients was 47 years and 46 (64%) of them were females. After 3 months, 77.5% of the patients had persistent dyspnea, 57.7% persistent fatigue, 15.5% persistent cough, and 8.5% persistent chest pain. At the 6th month, dyspnea and fatigue persisted in 33.8% and 22.5% of cases respectively while at the 12th month dyspnea persisted in 22.5% of cases. Old age, smoking, diabetes mellitus, severity of the disease, and hypoxemia on admission were associated factors with persistent symptoms. Our result added to the growing evidence that there are pulmonary sequelae in COVID-19 survivors, which may become a significant chronic global pulmonary health problem.","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140009786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Role of STREM-1 for early prediction of ventilator-associated pneumonia in pediatrics","authors":"Tarek Ahmed Abdelgawad, Maha Ahmad Anwar, Sondos Mohamed Magdy, Mohamed El-Sayed Abd El-Maksoud Abd El-Maksoud","doi":"10.1186/s43168-024-00268-z","DOIUrl":"https://doi.org/10.1186/s43168-024-00268-z","url":null,"abstract":"TREM-1 (setting off receptor imparted on myeloid cells-1) is an immunoreceptor. Neutrophils, monocytes/macrophages, and endothelial cells all express TREM-1. This work aimed to evaluate the role of STREM-1 in ventilator-associated pneumonia (VAP) early prediction in pediatrics. This case–control research involved 56 children aged from 1 month to 5 years old, who were admitted to the pediatric intensive care unit (PICU) and needed mechanical ventilation (MV), from January 2023 to June 2023. Subjects were equally allocated into two groups: VAP group and non-VAP group. There was significantly elevated serum STREM-1 after 72 h than at admission between both groups. There was significantly elevated STREM-1, procalcitonin (PCT), and C-reactive protein (CRP) after 72 h in the VAP group compared to the non-VAP group. There was a positive correlation between PCT and CRP after 72 h. STREM-1 at admission and after 72 h area under the curve (AUC) was 0.641 (0.502 to 0.765), 1.000 (0.936 to 1.000), with best cut-off value for prediction of VAP was > 185, > 230 with sensitivity 53.6%, 100% and specificity 67.9%, 100%, respectively. Serum sTREM-1 concentration is a reliable biomarker for predicting VAP in pediatrics received MV.","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139922619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Study of serum Ykl-40 level and its relationship to BODE index in patients with chronic obstructive pulmonary disease","authors":"Aya Elsayed Farrag, Anwar Ahmed Elganady, Enas Elsaid Mohammed, Abeer Shawky ElHadidi, Heba Ahmed Eshmawey","doi":"10.1186/s43168-024-00267-0","DOIUrl":"https://doi.org/10.1186/s43168-024-00267-0","url":null,"abstract":"Chronic obstructive pulmonary disease (COPD) is a significant global health concern characterized by growing rates of mortality and morbidity. The purpose of this work was to evaluate the serum YKL-40 level and its relationship to body mass index (BMI), obstruction of airflow, dyspnea, exercise capacity (BODE) index, and the extent of COPD. This prospective work was carried out on 70 adult male patients, allocated into three groups: group A—36 smokers with stable COPD with different degrees of severity; group B—19 smokers without COPD; and group C—15 healthy non-smokers as a control group. The BODE index was 5.56 ± 2.52. Prebronchodilator forced expiratory volume in 1 s (FEV1) and FVC were substantially decreased in group A contrasted to group B and group C (P value < 0.001). Prebronchodilator forced expiratory volume in 1/forced vital capacity (FEV1/FVC) ratio was substantially decreased in group A contrasted to groups B and C and lower in group B than in group C (P value < 0.001). Chest X-ray (CXR) signs of COPD and mMRC Dyspnea Scale were significantly higher in group A than in groups B and C (P value < 0.001). The 6-min walking test was substantially decreased in group A than in groups B and C and lower in group B than in group C (P value < 0.001 and 0.006 correspondingly). Serum YKL-40 was substantially greater in group A contrasted to group C (P value = 0.005). There was no correlation between serum YKL-40 and (BODE index, O2 saturation, or smoking index) in group A. A substantial positive association existed among serum YKL-40 and [degree of severity and white blood cells (WBCs)] in group A. Serum YKL-40 cannot predict the severity of COPD (P = 0.227 and AUC = 0.584) at cut-off > 0.394 with 80.65% sensitivity, 41.03% specificity, 52.1% PPV, and 72.7% NPV. Serum YKL-40 level was substantially greater in the COPD group contrasted to healthy non-smokers, no substantial association existed between serumYKL-40 and BODE index, O2 saturation, or smoking index. A substantial positive association existed between SerumYKL-40 and the degree of severity and WBCs.","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":"136 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139922549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Subclinical pleuro-pulmonary disease in patients with SLE: functional and radiological methods","authors":"Hanaa S. Hamed, Mohammed M. N. Abozaid, Enas Mekawy","doi":"10.1186/s43168-024-00266-1","DOIUrl":"https://doi.org/10.1186/s43168-024-00266-1","url":null,"abstract":"Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease with highest prevalence of chest involvement; however, early detection of subclinical pleuropulmonary diseases may improve the quality of life and prognosis of patients. This study aimed to identify the subclinical pleuro-pulmonary involvement in SLE patients without respiratory symptoms. A total of 228 patients diagnosed with SLE were recruited and subjected to high-resolution computed tomography (HRCT) chest, ultrasound (US) chest, and spirometry for further evaluation and finding of sub-clinical signs. Around 52.63% of patients had pulmonary involvement in HRCT, while in US, it was 73.68%. Ground glass opacity was observed in 31.58% of HRCT cases, and > 1/3 of patients had pleural thickness in US. Spirometry showed that 26.32% of patients had small airway disease. SLE patients with subclinical lung involvement were significantly female and younger and had shorter disease duration, p < 0.05 for all. SLE severity showed a significant negative correlation with lung function, and was positively correlated with pleural thickness and effusion, and pleural nodules in US finding. However, diaphragmatic excursion showed a negative correlation. Moreover, ground glass opacities, honey combing opacities, interlobular septal thickening, pleural thickness, and effusion in HRCT showed positive correlation with disease severity, p < 0.001 for all, yet, the mosaic pattern showed a negative relationship. The radiological assessments of SLE patients via HRCT and ultrasound unveiled prevalent findings such as ground glass opacities and pleural abnormalities. The severity of SLE correlated significantly with pulmonary function tests in a negative way, plus the positive correlation with lung opacities and pleural abnormalities.","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":"86 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139922623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Endobronchial chondrosarcoma presenting as recurrent pneumonia: a rare pulmonary tumour","authors":"Rahul Kumar Gupta, Amita Mason, Shirazi Nadia, Manoj Kumar","doi":"10.1186/s43168-023-00231-4","DOIUrl":"https://doi.org/10.1186/s43168-023-00231-4","url":null,"abstract":"Chondrosarcoma is a group of bone tumours made up of cells responsible for cartilage production. It usually affects the axial skeleton, including the pelvis, scapula and base of the skull with frequent metastasis to the lungs. Primary pulmonary involvement with chondrosarcoma is rarely seen. In this case report, we will discuss a case of endobronchial chondrosarcoma presenting as recurrent pneumonia. Only a few cases of primary pulmonary chondrosarcoma are reported with endobronchial involvement, therefore being quite rare.","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":"145 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139771154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Study of the prevalence and predictive factors of sleep-disordered breathing in patients with interstitial lung diseases","authors":"Nabila Ibrahim Laz, Mohammad Farouk Mohammad, Mona Mahmoud Srour, Waleed Ramadan Arafat","doi":"10.1186/s43168-024-00264-3","DOIUrl":"https://doi.org/10.1186/s43168-024-00264-3","url":null,"abstract":"Interstitial lung diseases (ILDs) are parenchymal lung conditions that are chronic, progressive, and have a high morbidity and mortality rate. Due to restrictions in their gas exchange and ventilatory dysfunction, ILD patients are probably at risk for sleep-disordered breathing (SDB). Sixty-nine patients with diffuse parenchymal lung diseases identified by high-resolution computed tomography (HRCT) chest were included in the study. All patients were assessed by the STOP-BANG questionnaire (SBQ), Epworth sleepiness scale (ESS), and full-night polysomnography (PSG) for diagnosis and classification of SDB. The aim of the study is to examine the prevalence and risk factors for SDB in ILD. Among the study group hypersensitivity pneumonitis (HP) was the most prevalent ILD, accounting for 63.8% of cases. Out of 69 individuals, 42 (60.9%) had SDB, 57.1% of those with SDB had obstructive sleep apnea (OSA), and the majority of those with OSA had mild degrees (21.7%, n = 15). OSA is significantly common in ILD patients. Higher left atrium diameter and oxygen desaturation index (ODI) are predictive factors of SDB. To facilitate early diagnosis and therapy, PSG should be performed on ILD patients at high risk (such as males, individuals with high ESS scores, SBQ scores, and left atrium diameter). Retrospectively registered, registration number is NCT06012526, date of registration August 25, 2023.","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139771251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to prone positioning in COVID-19 patients with acute respiratory distress syndrome: a retrospective observational study","authors":"Zeinab Adawy, Ayman Iskandarani, Abeer Alharbi, Yara A. Iskandarani, Gufran Salem, Dalya A. Iskandarani, Abdul Rahman H. Ali, Mohammed A. Salem, Eman Sobh","doi":"10.1186/s43168-024-00261-6","DOIUrl":"https://doi.org/10.1186/s43168-024-00261-6","url":null,"abstract":"COVID-19 pneumonia and respiratory failure are the leading causes of death in COVID-19 patients. Prone positioning was hypothesized to improve oxygenation in ARDS patients and is being studied in COVID-19, but the current evidence is still unclear regarding survival and hospitalization. We aimed to investigate the effect of prone positioning on oxygenation in patients with COVID-19 pneumonia and ARDS and to examine the factors associated with better/worse outcomes. A retrospective record-based cohort study included all confirmed COVID-19 patients with pneumonia and ARDS who underwent prone positioning admitted to King Fahad Hospital, Medina, Saudi Arabia, during 2020–2021. This study included 75 cases (mean age 60.3 ± 15.7 year, 50 (66.7%) males), and all fulfilled the definition of ARDS. There was a significant improvement in oxygenation (PaO2 and PaO2/FIO2) following prone positioning (53.5 ± 6.8 vs. 60.4 ± 8.2 mmHg, p < 0.001 for PaO2 supine and prone and 120.3 ± 35 vs. 138 ± 40.2, p < 0.001 for PaO2/FIO2 supine and prone respectively). There was no significant difference in age, gender, smoking, or number of comorbidities between survivors and non-survivors. Survivors had significantly higher baseline PaO2 (p 0.018) and PF ratio (p 0.001) compared to non-survivors. They had also less severe inflammation and organ damage observed as significantly lower ferritin (p 0.001), D-dimer (p 0.026), aspartate aminotransferase (p 0.02), urea (p 0.032), creatinine (p 0.001), and higher platelet counts (p 0.001). Intubation and high-moderate comorbidity risk categories were associated with non-survival (p 0.001 and p 0.014, respectively). Prone positioning is useful in the improvement of oxygenation in intubated and awake patients with COVID-19 pneumonia and ARDS. Intubation and high comorbidity risk categories were associated with non-survival.","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139666922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluation of brain white matter changes on MRI in patients newly diagnosed with obstructive sleep apnea compared with the control group","authors":"Farzaneh Khoroushi, Yasmin Davoodi, Amirhossein Fathabadi, Reihane Bakhshi, Yasamin Sharifian, Maryam Salehi, Leila Ghofranyha, Ehsan Hassannejad, Farnaz Kharaghani","doi":"10.1186/s43168-024-00257-2","DOIUrl":"https://doi.org/10.1186/s43168-024-00257-2","url":null,"abstract":"Obstructive sleep apnea (OSA) is nowadays introduced as a risk factor for white matter brain changes. Research on OSA and white matter changes provides contradictory evidence for the contextual link between the two conditions. This study aimed to determine the prevalence and severity of OSA and changes in the brain's white matter and the relationship between severity levels of both diseases. This was a cross-sectional study in which 40 patients with OSA and 40 patients without OSA underwent polysomnography to determine the severity of OSA and MRI for detecting white matter changes. The severity of white matter changes was classified according to the age-related white matter change (ARWMC) score, and the severity of OSA based on the apnea–hypopnea index (AHI). To evaluate the independent effect of OSA on white matter changes, a multivariate regression model, including the severity of OSA and risk factors, was used. 76.5% of affected people did not show any changes, and from 13 (32.5%) patients with OSA who experienced white matter changes, 10% were mild, and 22.5% were moderate to severe changes. The white matter changes score increased with increasing OSA severity. The univariate analysis also showed a significant positive correlation between OSA severity and ARWMC score. Our major finding was that moderate to severe OSA was independently associated with the prevalence of white matter changes. We also observed a higher prevalence of moderate to severe OSA associated with increasing white matter changes, suggesting that the severity of the disease affects brain structural modification.","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139667326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of interleukin 6 (IL-6) as a marker of inflammation among adult patients with pulmonary tuberculosis in Zaria, Nigeria","authors":"Mairiga Sa’ad, Abdullah A. Abba, Bolanle Olufunke Priscilla Musa, Abdurrahman El-fulaty Ahmad, Musa Mohammed","doi":"10.1186/s43168-024-00263-4","DOIUrl":"https://doi.org/10.1186/s43168-024-00263-4","url":null,"abstract":"Tuberculosis (TB) remains a significant cause of morbidity and mortality worldwide. Complications of the disease are associated with the host’s inflammatory response. The study aimed to determine the plasma level of interleukin-6 as a biomarker of inflammation among adult patients with pulmonary tuberculosis in Zaria. Method This was a cross-sectional study. Blood samples were taken from 30 treatment-naïve (TN), 30 treatment-experienced (TE), and 30 healthy controls (HC). Results The means and standard deviations of interleukin-6 plasma levels for tuberculosis treatment naive, treatment experience and apparently healthy control are 64.4 ± 19.4, 57.9 ± 21.4, and 49.9 ± 7.7 pg/L, respectively. This study found upregulated plasma levels of interleukin-6 among treatment naive compared to treatment experience but the statistically not significant and significantly upregulated level of interleukin 6 among treatment naïve compared to apparently healthy control (p = 0.006). There was a downregulated level of interleukin-6 among HC compared to TN and TE but statistically not significant. Conclusion The role of interleukin-6 as a surrogate biomarker for the management of patients with pulmonary tuberculosis is promising but requires further study.","PeriodicalId":22426,"journal":{"name":"The Egyptian Journal of Bronchology","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139648042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}